SI1347764T1 - Gelni sestavek na alkoholni osnovi za zdravljenje hipogonadizma s trans-skrotalno aplikacijo - Google Patents

Gelni sestavek na alkoholni osnovi za zdravljenje hipogonadizma s trans-skrotalno aplikacijo

Info

Publication number
SI1347764T1
SI1347764T1 SI200130714T SI200130714T SI1347764T1 SI 1347764 T1 SI1347764 T1 SI 1347764T1 SI 200130714 T SI200130714 T SI 200130714T SI 200130714 T SI200130714 T SI 200130714T SI 1347764 T1 SI1347764 T1 SI 1347764T1
Authority
SI
Slovenia
Prior art keywords
hypogonadism
treatment
transscrotal
alcohol
gel composition
Prior art date
Application number
SI200130714T
Other languages
English (en)
Inventor
Bernd Dr August Wolff Gmbh & Co Schulze
Eberhard Nieschlag
Original Assignee
August Wolff Gmbh & Co Kg Arzenmittel Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by August Wolff Gmbh & Co Kg Arzenmittel Dr filed Critical August Wolff Gmbh & Co Kg Arzenmittel Dr
Publication of SI1347764T1 publication Critical patent/SI1347764T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
SI200130714T 2000-12-22 2001-12-20 Gelni sestavek na alkoholni osnovi za zdravljenje hipogonadizma s trans-skrotalno aplikacijo SI1347764T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10064205 2000-12-22
EP01985426A EP1347764B1 (de) 2000-12-22 2001-12-20 Gelzusammensetzung auf alkoholischer basis zur behandlung von hypogonadismus durch transskrotale applikation
PCT/EP2001/015123 WO2002051421A2 (de) 2000-12-22 2001-12-20 Gelzusammensetzung und transskrotale applikation einer zusammensetzung zur behandlung von hypogonadismus

Publications (1)

Publication Number Publication Date
SI1347764T1 true SI1347764T1 (sl) 2007-06-30

Family

ID=7668398

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200130714T SI1347764T1 (sl) 2000-12-22 2001-12-20 Gelni sestavek na alkoholni osnovi za zdravljenje hipogonadizma s trans-skrotalno aplikacijo

Country Status (17)

Country Link
US (2) US20040044086A1 (sl)
EP (1) EP1347764B1 (sl)
AT (1) ATE356626T1 (sl)
CA (1) CA2432534C (sl)
CY (1) CY1106595T1 (sl)
CZ (1) CZ20031761A3 (sl)
DE (2) DE50112206D1 (sl)
DK (1) DK1347764T3 (sl)
EE (1) EE05318B1 (sl)
ES (1) ES2283446T3 (sl)
HR (1) HRP20030510A2 (sl)
HU (1) HUP0600234A3 (sl)
PL (1) PL206702B1 (sl)
PT (1) PT1347764E (sl)
SI (1) SI1347764T1 (sl)
SK (1) SK7932003A3 (sl)
WO (1) WO2002051421A2 (sl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
MY139721A (en) * 2002-04-19 2009-10-30 Cpex Pharmaceuticals Inc Pharmaceutical composition
EP1634583A1 (en) * 2004-09-09 2006-03-15 Laboratoires Besins International Testosterone gels comprising propylene glycol as penetration enhancer
JP2008512425A (ja) * 2004-09-09 2008-04-24 ラボラトワール ブザン アンテルナスィヨナル 透過促進剤としてのプロピレングリコールを含むテストステロンゲル
US20070088012A1 (en) * 2005-04-08 2007-04-19 Woun Seo Method of treating or preventing type-2 diabetes
TR201815853T4 (tr) 2005-10-12 2018-11-21 Besins Healthcare Sarl Hipogonadizmin tedavisinde kullanıma yönelik geliştirilmiş testosteron jeli.
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US20130040923A1 (en) 2011-05-13 2013-02-14 Trimel Pharmaceuticals Corporation Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3860712A (en) * 1973-04-16 1975-01-14 Sterling Drug Inc Composition and method for treatment of acne or seborrhea
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
CA1249968A (en) * 1984-04-05 1989-02-14 Kazuo Kigasawa Ointment base
US4725439A (en) * 1984-06-29 1988-02-16 Alza Corporation Transdermal drug delivery device
US5776923A (en) * 1993-01-19 1998-07-07 Endorecherche, Inc. Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
DK3994A (da) * 1994-01-10 1995-07-11 Frank Nielsen CDopbevaringssystem hvor CDcoverne monteres på en skinne
EP0952833A1 (de) * 1996-05-02 1999-11-03 Azupharma GmbH Topische penile androgen-applikation zur behandlung der erektilen dysfunktion
EP0954260A1 (en) * 1996-05-22 1999-11-10 Diversified Pharmaceuticals, Inc. Compositions, methods and devices for the transdermal delivery of drugs
US5968919A (en) * 1997-10-16 1999-10-19 Macrochem Corporation Hormone replacement therapy drug formulations for topical application to the skin
CN1172674C (zh) * 1997-11-10 2004-10-27 赛勒吉药物股份有限公司 促进渗透和减少刺激的系统
DE19803193C1 (de) * 1998-01-28 1999-07-15 August Wolff Gmbh & Co Arzneim Pharmazeutische Zusammensetzung mit Lecithin und alpha-Bisabolol als Penetrationsbeschleuniger
WO2002011768A1 (en) * 2000-08-03 2002-02-14 Antares Pharma Ipl Ag Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20040072810A1 (en) * 2001-11-07 2004-04-15 Besins International Belgique Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
DE60139625D1 (de) * 2001-12-07 2009-10-01 Besins Int Belgique Gel oder Lösung enthaltend Dihydrotestosterone, deren Herstellungsverfahren und Verwendung

Also Published As

Publication number Publication date
PL366101A1 (en) 2005-01-24
CA2432534C (en) 2009-09-22
CY1106595T1 (el) 2012-01-25
CA2432534A1 (en) 2002-07-04
DE20121209U1 (de) 2002-06-20
DK1347764T3 (da) 2007-07-23
WO2002051421A3 (de) 2002-11-07
EP1347764A2 (de) 2003-10-01
HRP20030510A2 (en) 2005-04-30
ATE356626T1 (de) 2007-04-15
HUP0600234A3 (en) 2011-04-28
ES2283446T3 (es) 2007-11-01
US20100317631A1 (en) 2010-12-16
US20040044086A1 (en) 2004-03-04
PT1347764E (pt) 2007-06-01
HUP0600234A2 (en) 2006-07-28
EE200300305A (et) 2003-12-15
EE05318B1 (et) 2010-08-16
DE50112206D1 (de) 2007-04-26
CZ20031761A3 (cs) 2004-01-14
EP1347764B1 (de) 2007-03-14
SK7932003A3 (en) 2003-11-04
WO2002051421A2 (de) 2002-07-04
PL206702B1 (pl) 2010-09-30

Similar Documents

Publication Publication Date Title
BR0113670A (pt) Composição farmacêutica e método para tratar hipogonadismo
HK1071521A1 (en) Use of a composition comprising cis-clomiphene andtrans-clomiphene in the preparation of a medicament for increasing serum levels of testosterone
SI1347764T1 (sl) Gelni sestavek na alkoholni osnovi za zdravljenje hipogonadizma s trans-skrotalno aplikacijo
AU3162901A (en) Reducing damage to hair during oxidative processes
WO2001070210A3 (en) Methods for improving size and appearance of a wound
NZ504423A (en) Composition having enhanced penetration capabilities and irritation reducing systems
WO2001017543A3 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
CA2418167A1 (en) Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
GB9714274D0 (en) Pharmaceutical composition
ES2166549T3 (es) Procedimiento de preparacion de 17-esteres de 9alfa,21-dihalo-pregnan-11beta,17alfadiol-20-onas.
BRPI0209619B8 (pt) agente promotor de crescimento capilar
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
AU4162402A (en) Process
BR0011261B1 (pt) composiÇço oral compreendendo perlita, e, uso de perlita.
SG165144A1 (en) 1,2-substituted 2,3-dihydro-1h- 5,9-dioxacyclohepta[f]inden-7-ones and 7- substituted benzo[b][1,4]dioxepin-3-ones
AU4127300A (en) Use of cellulose microfibrils in fermented milk compositions
MD1580G2 (ro) Agent antimutagen
MY157231A (en) Aminocyclohexyl ether compounds and uses thereof
UA31828A (uk) Композиція інгредієнтів до горілки особливої "прикарпаття"